BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12136481)

  • 1. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
    Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis].
    Matl I; Matousovic K; Herout V; Konecný K; Kovác A; Rychlík I; Sobotová D; Roland R; Zdichyncová I; Lánská V
    Cas Lek Cesk; 1997 Feb; 136(4):120-3. PubMed ID: 9221182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
    Mukhin NA; Tareeva IE; Krasnova TN; Shilov EM; Miroshnichenko NG
    Ter Arkh; 1995; 67(8):13-5. PubMed ID: 7482320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A; Rasić S; Rebić D; Uncanin S
    Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of chronic glomerulonephritis in chronic opisthorchiasis].
    Beloborodova EI; Zibnitskaia LI; Kaliuzhina EV
    Ter Arkh; 2005; 77(11):44-9. PubMed ID: 16404862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rapidly progressive glomerulonephritis in ANCA-associated vasculitis: a course, treatment efficacy, prognosis].
    Tomilina NA; Biriukova LS; Egorova ET; Sukhanov AV; Stoliarevich ES; Kupavtseva OA; Fedorova ND; Frolov AV; Trushkin RN; Kurenkova LG
    Ter Arkh; 2008; 80(6):15-24. PubMed ID: 18655470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
    Rumiantsev ISh; Kaznacheeva IG; Abdiadilova LV; Kozlov VV
    Ter Arkh; 1992; 64(6):35-9. PubMed ID: 1440334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.